PMCPA Case Library

1,752 PMCPA Rulings.
Every One Analysed.

The only structured, searchable PMCPA case library in the UK. Expert video walkthroughs, podcast episodes, and MCQ assessments on every ruling — so you understand why companies breach the Code, not just that they did.

▶ Video analysis per case
🎧 Podcast per case
✍ MCQ + CPD certificate
🔒 From £299/year
1752+
Case Studies
5 min
Per Video
5 pts
Per Case Passed
8
Themes
📚
Subscribe for full case library access
Read free summaries below, or subscribe to unlock expert video walkthroughs, podcast audio and CPD certificates.
Free — Browsing
✓ Browse all 1752+ case titles
✓ Filter by theme & therapy area
✓ See case reference, company & outcome
Search by company or clause
Video walkthroughs
Podcast episodes
MCQ assessments & CPD certificates
Subscribed — Full Access
✓ Search by company, clause & case ref
✓ Expert video walkthrough per case
✓ Podcast episode per case
✓ MCQ quiz — 5 CPD points per pass
✓ Personalised CPD completion certificate
✓ New cases added monthly
Subscribe from £299/year →
Search by company, clause, case reference... 🔒
Therapy Area: All areas Other (360) Oncology (218) Cardiovascular (189) Respiratory (178) CNS & Neurology (169) Infectious Diseases (115) Diabetes (114) Rare Diseases (104) Immunology & Rheumatology (84) Dermatology (67) Obesity & Weight Management (63) Musculoskeletal & Bone (60) Ophthalmology (31)
🔒 Subscribers only
AUTH/2814/12/15
HCP Hospitality & Meetings Not Upheld 🏥 Cardiovascular ▶ Video 🎙 Podcast
Boehringer Ingelheim symposia at ESC Congress (Pradaxa)
An anonymous, non-contactable UK health professional complained about Boehringer Ingelheim medical symposia at the European Society of Cardiology (ESC) Congress in London (29 Aug–2 Sep 2015). The…
Clauses: NONE
🔒 Subscribers only
AUTH/2795/9/15
HCP Hospitality & Meetings Not Upheld 🏥 Immunology & Rheumatology ▶ Video 🎙 Podcast
Napp Pharmaceuticals
An anonymous, non-contactable ‘NHS whistleblower’ complained about Napp’s promotion of Remsima (infliximab), a biosimilar of Remicade, focusing on: (1) a UK HCP meeting held in Norway and (2)…
Clauses: NONE
🔒 Subscribers only
AUTH/2790/8/15
HCP Hospitality & Meetings Not Upheld 🏥 Other ▶ Video 🎙 Podcast
Chugai
An anonymous, non-contactable complainant (claiming to be an ex-employee and the complainant in AUTH/2749/2/15) submitted a new complaint about consultancy arrangements.The complaint was closely si…
Clauses: NONE
🔒 Subscribers only
AUTH/2747/1/15
HCP Hospitality & Meetings Not Upheld 🏥 Oncology ▶ Video 🎙 Podcast
Astellas Pharma Europe
An anonymous, non-contactable health professional complained about arrangements for a Pan-European Uro-oncology Advisory Board Meeting held in Milan (airport hotel) on 27/28 February 2014.The compl…
Clauses: NONE
🔒 Subscribers only
AUTH/2794/9/15
Off-label Promotion Upheld 🏥 Dermatology ▶ Video 🎙 Podcast
Bayer v Actavis
Bayer complained about a four-page Levosert leavepiece (ref UK/LE/0001/01-15b) issued by Actavis UK Ltd.The leavepiece headline asked: “Can a single IUS be suitable for so many women?”The leave…
🔒 Subscribers only
AUTH/2792/9/15
Social Media & Digital Not Upheld 🏥 Respiratory ▶ Video 🎙 Podcast
GlaxoSmithKline
An anonymous complainant (described themself as a respiratory physician) alleged a GlaxoSmithKline (GSK) corporate press release about the SUMMIT COPD study was deliberately misleading.The press re…
Clauses: NONE
🔒 Subscribers only
AUTH/2791/9/15
Data & Publications Upheld 🏥 Cardiovascular ▶ Video 🎙 Podcast
Bayer breach over Xarelto leavepiece
An anonymous, non-contactable complainant challenged a Bayer sales leavepiece: “Think NOACs and Renal Impairment in Non-Valvular AF. Think Xarelto” (ref L.GB.12.2014.9153a).The leavepiece inclu…
🔒 Subscribers only
AUTH/2787/8/15
Social Media & Digital Not Upheld 🏥 Respiratory ▶ Video 🎙 Podcast
GSK
GlaxoSmithKline (GSK) voluntarily admitted that some UK online advertisements for Incruse Ellipta (umeclidinium bromide) plus Relvar Ellipta (fluticasone furoate/vilanterol trifenatate) did not mee…
Clauses: NONE
🔒 Subscribers only
AUTH/2786/8/15
Social Media & Digital Not Upheld 🏥 CNS & Neurology ▶ Video 🎙 Podcast
Keppra medical information email reposted on ESNA website
An NHS medicines information pharmacist complained about content on the Epilepsy Nurse Association (ESNA) website titled “Data on Keppra v generic levetiracetam”.The ESNA page reproduced text f…
Clauses: NONE
🔒 Subscribers only
AUTH/2785/8/15
Social Media & Digital Not Upheld 🏥 Ophthalmology ▶ Video 🎙 Podcast
Bayer
An anonymous, non-contactable consultant complained about Bayer’s promotion of Eylea (aflibercept), alleging discussions comparing Eylea with Lucentis (ranibizumab) using off-licence/off-label da…
Clauses: NONE
🔒 Subscribers only
AUTH/2784/7/15
HCP Hospitality & Meetings Not Upheld 🏥 Other ▶ Video 🎙 Podcast
Chiesi
An anonymous, non-contactable ex-employee complained about a presentation delivered at a Chiesi UK sales conference/meeting (May 2015).The complainant alleged the presenter realised mid-session tha…
Clauses: NONE
🔒 Subscribers only
AUTH/2782/7/15
HCP Hospitality & Meetings Not Upheld 🏥 Respiratory ▶ Video 🎙 Podcast
GSK
GlaxoSmithKline (GSK) voluntarily admitted that patient support items for the Ellipta inhaler were handed out from an exhibition stand at a third-party meeting for nurses (April 2015).An account ma…
Clauses: NONE
🔒 Subscribers only
AUTH/2781/7/15
HCP Hospitality & Meetings Not Upheld 🏥 Other ▶ Video 🎙 Podcast
AbbVie v Bristol-Myers Squibb
Clauses: NONE
🔒 Subscribers only
AUTH/2779/7/15
HCP Hospitality & Meetings Not Upheld 🏥 Other ▶ Video 🎙 Podcast
Merck Sharp & Dohme
A general practitioner complained about the conduct of a named representative (who at the time worked for Organon, later acquired into Merck Sharp & Dohme’s responsibility).Allegations includ…
Clauses: NONE
🔒 Subscribers only
AUTH/2778/7/15
Off-label Promotion Not Upheld 🏥 Dermatology ▶ Video 🎙 Podcast
Ipsen
Merz complained about two Ipsen leavepieces promoting Dysport (botulinum toxin type A) that discussed dose ratios versus other BoNT-A products (including Xeomin and Botox).Leavepiece 1 (ref UK/DYS0…
Clauses: NONE
🔒 Subscribers only
AUTH/2777/7/15
HCP Hospitality & Meetings Not Upheld 🏥 Other ▶ Video 🎙 Podcast
Sanofi
An anonymous, non-contactable complainant alleged Sanofi key account managers’ (KAMs) business cards breached the Code because they featured a medicine brand name and lacked prescribing informati…
Clauses: NONE
🔒 Subscribers only
AUTH/2776/7/15
Off-label Promotion Not Upheld 🏥 Cardiovascular ▶ Video 🎙 Podcast
Bayer
Bristol-Myers Squibb and Pfizer complained about a Xarelto (rivaroxaban) gate-fold leavepiece: “For elderly patients taking aspirin for stroke prevention… It’s time to rethink their protectio…
Clauses: NONE
🔒 Subscribers only
AUTH/2775/6/15
HCP Hospitality & Meetings Not Upheld 🏥 Respiratory ▶ Video 🎙 Podcast
Boehringer Ingelheim
An anonymous, non-contactable complainant (described as a hospital pharmacist) raised concerns about a Boehringer Ingelheim programme supplying Ofev (nintedanib) free of charge/at a confidential di…
Clauses: NONE
🔒 Subscribers only
AUTH/2774/6/15
Off-label Promotion Not Upheld 🏥 CNS & Neurology ▶ Video 🎙 Podcast
Pfizer gabapentin pharmacy “patient alert” on PMR systems
A head of medicines management (CCG) complained about a Pfizer-supported “patient alert” that appeared on some community pharmacy electronic dispensing/PMR systems when gabapentin was entered/d…
Clauses: NONE
🔒 Subscribers only
AUTH/2758/5/15
Off-label Promotion Upheld 🏥 Other ▶ Video 🎙 Podcast
Stirling Anglian
Galen complained about Stirling Anglian’s promotion of CosmoCol (Macrogol 3350 plus electrolytes) via (1) an “abbreviated advertisement” in MIMS (March 2015) and (2) a one-page leavepiece (pr…
🔒 Subscribers only
AUTH/2756/5/15
Social Media & Digital Upheld 🏥 CNS & Neurology ▶ Video 🎙 Podcast
Merck Serono call-rate targets
An anonymous employee complained that, after a neurology leadership change (Jan 2015), the neurology sales team was targeted to see six prescribing customers daily.What began as a March 2015 “add…
Clauses: 9.1,9.2
🔒 Subscribers only
AUTH/2755/5/15
Off-label Promotion Not Upheld 🏥 Musculoskeletal & Bone ▶ Video 🎙 Podcast
A Menarini misleading cost messaging and email permission failures in
A head of medicines optimisation complained about a promotional email sent by A Menarini to payers, formulary committees, prescribing advisors and medicines management teams.The email/attachment hi…
Clauses: NONE
🔒 Subscribers only
AUTH/2754/5/15
HCP Hospitality & Meetings Not Upheld 🏥 CNS & Neurology ▶ Video 🎙 Podcast
Merck Serono breach over MS nurse call frequency driven by 6-contacts/day target (AUTH/2754/5/15)
An anonymous, non-contactable complainant (described as a senior MS nurse specialist in an NHS trust) complained that Merck Serono representatives visited very frequently, often without an appointm…
Clauses: NONE
🔒 Subscribers only
AUTH/2763/5/15
Social Media & Digital Not Upheld 🏥 Other ▶ Video 🎙 Podcast
AstraZeneca
An ABPI-funded paper in Current Medical Research & Opinion (published online 5 May 2015) assessed whether results of company-sponsored trials linked to new medicines approved by EMA in 2012 wer…
Clauses: NONE
← Prev 36 37 38 39 40 41 42 Next → Page 39 of 73 — 1752 cases
Unlock the Full Case Library
Annual subscription — instant access, cancel anytime.
🏆
The only PMCPA case library of its kind
No other provider publishes a structured, searchable library of PMCPA rulings with video and podcast. A single half-day compliance workshop from a specialist provider typically costs £499+ — for one session. Individual access here is £299 for a full year of 2,000+ cases.
PMCPA Case Library — Team (100 seats)
Custom pricing
tailored to your team size
Bulk pricing available — contact us for a quote
Enquire for bulk pricing →
Individual
For a single learner
£299
per year
Less than a single half-day workshop
  • 1 user seat
  • All 1752+ case studies
  • Video + podcast per case
  • MCQ quiz per case
  • 5 points per case passed
  • New cases added monthly
Create account or sign in to buy
Team 25+
25+ team members
Custom pricing
tailored to your team size
Bulk pricing available — contact us for a quote
  • 25 user seats
  • All case studies included
  • Video, podcast & MCQ per case
  • Team progress dashboard
  • Bulk seat management
  • Priority support
Enquire for bulk pricing →

Questions? Email [email protected]  ·  14-day money-back guarantee  ·  Annual subscription, auto-renews